tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ANIP Stock Latest News

ANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
The FlyANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
2d ago
ANIP
ANI Pharmaceuticals completes acquisition of Alimera Sciences
PremiumThe Fly
ANI Pharmaceuticals completes acquisition of Alimera Sciences
4d ago
ALIM
ANIP
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
PremiumPress Releases
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
4d ago
ANIP
ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences
PremiumThe Fly
ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences
4d ago
ALIM
ANIP
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
PremiumPress Releases
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
4d ago
ANIP
ANI Pharmaceuticals launches Promethazine Hydrochloride
PremiumThe FlyANI Pharmaceuticals launches Promethazine Hydrochloride
7d ago
ANIP
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
Premium
Press Releases
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
7d ago
ANIP
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
Premium
The Fly
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
9d ago
AR
MS
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
PremiumThe Fly
ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
9d ago
ALIM
ANIP
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
PremiumPress Releases
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
9d ago
ANIP
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
PremiumThe Fly
ANI Pharmaceuticals downgraded to Hold from Buy at Truist
9d ago
ALIM
ANIP
ANI says working in ‘good faith’ to close Alimera acquisition
PremiumThe Fly
ANI says working in ‘good faith’ to close Alimera acquisition
9d ago
ALIM
ANIP
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
PremiumPress ReleasesANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
9d ago
ANIP
ANI Pharmaceuticals Announces Debt Clearance and Notes Sale
Premium
Company Announcements
ANI Pharmaceuticals Announces Debt Clearance and Notes Sale
1M ago
8K
ANIP
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
Premium
Press Releases
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
1M ago
ANIP
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
PremiumPress Releases
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
1M ago
ANIP
ANI Pharmaceuticals announces proposed convertible senior notes offering
PremiumThe Fly
ANI Pharmaceuticals announces proposed convertible senior notes offering
1M ago
ANIP
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
PremiumPress Releases
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
1M ago
ANIP
ANI Pharmaceuticals raises FY24 adj EPS view to $4.38-$4.82 from $4.26-$4.67
PremiumThe Fly
ANI Pharmaceuticals raises FY24 adj EPS view to $4.38-$4.82 from $4.26-$4.67
1M ago
ANIP
ANI Pharmaceuticals reports Q2 adjusted EPS $1.02, consensus 95c
PremiumThe FlyANI Pharmaceuticals reports Q2 adjusted EPS $1.02, consensus 95c
1M ago
ANIP
ANIP Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ANIP Upcoming Earnings Report: What to Expect?
2M ago
ANIP
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
Premium
Press Releases
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
2M ago
ANIP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >